This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
26 Oct 2011

LIVE FROM CPhI Worldwide: New Concept in Cancer Treatment

Latvian Virotherapy Center has in-troduced a treatment for oncological diseases with virotherapy medication Rigvir, an antitumour medication of viral origin.

Latvian Virotherapy Center has in­troduced a treatment for oncological diseases with virotherapy medication Rigvir, an antitumour medication of viral origin, which contains a live, natural ECHO group enterovirus with oncotropic and oncolytic qualities or the ability to find and destroy malignant cells.

 

Rigvir also functions as an im­munomodulator, activating, and normalizing the immune system. The medication is nonpathogenic, not genetically modified, and well tolerated. It is registered in the EU country Latvia and available in Lat­via’s pharmacies.

 

Virotherapy is a type of biotherapy for malignant tumours. At the basis of virotherapy lies the selective influ­ence of a virus on tumour cells. The method is already being applied by Latvia’s leadin

Related News